NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-157-1993-1-AU-08 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE AU DIV 11338/99 Abandoned
NCI E-003-1998-0-PCT-02 Therapeutic Blockage of Icer Synthesis to Prevent Icer-Mediated Inhibition of Immune Cell Activity PCT PCT PCT/US1999/000967 Expired
NCI E-022-1998-0-PCT-02 Alkenyldiarymethane Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors PCT PCT PCT/US1999/000916 Expired
NIDDK E-253-1999-1-JP-05 Methods for Reducing Intraocular Pressure JP National Stage 2000-559875 Abandoned
NCI E-003-1998-0-JP-06 Therapeutic Blockade of Icer Synthesis To Prevent Icer-Mediated Inhibition of Immune Cell Activity JP National Stage 2000-533554 Abandoned
NCI E-022-1998-0-JP-03 ALKENYLDIARYLMETHANE NON-NUCLEOSIDE HIV-1 REVERSE TRANSCRIPTASE INHBIBITORS (NNRTIS) JP National Stage 2000-540102 Abandoned
NCI E-003-1998-0-EP-05 Therapeutic Blockade of Icer Synthesis To Prevent Icer-Mediated Inhibition of Immune Cell Activity EP National Stage 99903134.7 Abandoned
NCI E-022-1998-0-EP-04 ALKENYLDIARYLMETHANE NON-NUCLEOSIDE HIV-1 REVERSE TRANSCRIPTASE INHBIBITORS (NNRTIS) EP National Stage 99902293.2 Abandoned
NIEHS E-080-1994-0-US-02 DIAGNOSTIC METHODS AND GENE THERAPY USING REAGENTS DERIVED FROM THE HUMAN METASTASIS SUPPRESSOR GENE KAI1 US DIV 09/232,507 Abandoned
NIDDK E-174-1998-0-US-01 Methods for Delivering Biologically Active Molecules Into Cells US 60/116,240 Abandoned
NCI E-003-1998-0-AU-03 Therapeutic Blockade of Icer Synthesis To Prevent Icer-Mediated Inhibition of Immune Cell Activity AU National Stage 23227/99 Abandoned
NCI E-003-1998-0-CA-04 Therapeutic Blockade of Icer Synthesis To Prevent Icer-Mediated Inhibition of Immune Cell Activity CA National Stage 2321993 Abandoned
NCI E-022-1998-0-CA-05 ALKENYLDIARYLMETHANE NON-NUCLEOSIDE HIV-1 REVERSE TRANSCRIPTASE INHBIBITORS (NNRTIS) CA National Stage 2317942 Abandoned
NIDCD E-264-1997-0-PCT-02 LIPOOLIGOSACCHARIDE-BASED VACCINE FOR PREVENTIONOF MORAXELLA (BRANHAMELLA) CATARRHALIS INFECTIONS IN MAMMALS PCT PCT PCT/US1999/000590 Expired
NIAID E-142-1997-0-PCT-02 APPLICATOR SYSTEM AND METHOD OF USE PCT PCT PCT/US1999/000614 Expired
NIDCD E-264-1997-0-CN-08 LIPOOLIGOSACCHARIDE-BASED VACCINE FOR PREVENTION OF MORAXELLA (BRANHAMELLA) CATARHALIS INFECTIONS IN MAMMALS CN National Stage 99802142.3 Abandoned
NIDCD E-264-1997-0-HK-09 LIPOOLIGOSACCHARIDE-BASED VACCINE FOR PREVENTION OF MORAXELLA (BRANHAMELLA) CATARHALIS INFECTIONS IN HUMANS HK National Stage 01105951.5 Abandoned
NIDCD E-264-1997-0-JP-07 LIPOOLIGOSACCHARIDE-BASED VACCINE FOR PREVENTION OF MORAXELLA (BRANHAMELLA) CATARHALIS INFECTIONS IN MAMMALS JP National Stage 2000-539859 Abandoned
NIDCD E-264-1997-0-EP-06 LIPOOLIGOSACCHARIDE-BASED VACCINE FOR PREVENTION OF MORAXELLA (BRANHAMELLA) CATARHALIS INFECTIONS IN MAMMALS EP National Stage 99902170.2 Abandoned
NIDCD E-264-1997-0-IL-10 LIPOOLIGOSACCHARIDE-BASED VACCINE FOR PREVENTION OF MORAXELLA (BRANHAMELLA) CATARHALIS INFECTIONS IN MAMMALS IL National Stage 136903 Abandoned
NIDCD E-264-1997-0-MX-12 LIPOOLIGOSACCHARIDE-BASED VACCINE FOR PREVENTION OF MORAXELLA (BRANHAMELLA) CATARHALIS INFECTIONS IN HUMANS MX National Stage 006678 Abandoned
NIDCD E-264-1997-0-KR-11 LIPOOLIGOSACCHARIDE-BASED VACCINE FOR PREVENTION OF MORAXELLA (BRANHAMELLA) CATARHALIS INFECTIONS IN MAMMALS KR National Stage 10-2000-7007737 Abandoned
NIDCD E-264-1997-0-CA-05 LIPOOLIGOSACCHARIDE-BASED VACCINE FOR PREVENTION OF MORAXELLA (BRANHAMELLA) CATARHALIS INFECTIONS IN MAMMALS CA National Stage 2315746 Abandoned
NIDCD E-264-1997-0-AU-03 LIPOOLIGOSACCHARIDE-BASED VACCINE FOR PREVENTION OF MORAXELLA (BRANHAMELLA) CATARHALIS INFECTIONS IN HUMANS AU National Stage 22212/99 Abandoned
NIDCD E-264-1997-0-BR-04 LIPOOLIGOSACCHARIDE-BASED VACCINE FOR PREVENTION OF MORAXELLA (BRANHAMELLA) CATARHALIS INFECTIONS IN HUMANS BR National Stage PI9906902-4 Abandoned
NIAID E-070-1999-0-US-01 Novel HIV Related Peptides US 60/115,430 Abandoned
NCI E-147-1991-1-US-07 Methods Of Inhibiting The Growth of Cells Bearing LewisY Antigens Useing B1,B3, or B5 Targeted Immunoconjugates US DIV 09/227,693 6287562 Abandoned PDF
NIAID E-065-1998-0-PCT-02 BROAD SPECTRUM CHEMOKINE ANTAGONIST AND USES THEREOF PCT PCT PCT/US1999/000491 Expired
NCI E-021-1999-0-US-01 The CD4-CCR5 Interaction as a Target for Inhibitors of HIV Infection US 60/115,182 Abandoned
NIMH E-080-1999-0-US-01 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 US 60/115,252 Abandoned
NCI E-040-1996-0-US-07 METHODS AND COMPOSITIONS FOR TRANSFORMING DENDRITIC CELLS AND ACTIVATING T CELLS US National Stage 09/117,764 6734014 Expired PDF
NHLBI E-047-1999-0-US-01 NMI Modulation of Signal Transduction Through Association With Stat Proteins and Other Proteins US 60/115,037 Abandoned
NCI E-231-1998-0-US-01 Lentivirus Vector System US 60/115,247 Abandoned
NCI E-210-1998-0-US-01 Aspartic Protease Inhibitors, Compositions, and Associated Therapeutic Methods-- US 60/114,868 Abandoned
NCI E-094-1994-0-US-02 JANUS FAMILY KINASES AND IDENTIFICATION OF IMMUNE MODULATORS (JAK-3) US DIV 09/226,540 Abandoned
NCI E-094-1994-0-US-03 JANUS FAMILY KINASES AND IDENTIFICATION OF IMMUNE MODULATORS (JAK-3) US DIV 09/226,541 Abandoned
NCI E-039-1996-0-US-03 Anti-Viral Pharmaceutical Compositions Containing Saturated 1,2-Dithiaheterocyclic Compounds And Uses Thereof US National Stage 09/214,331 6046228 Abandoned PDF
NCI E-194-1998-0-US-01 Calcium Channel Compositions and Methods of Use Thereof US 60/114,359 Abandoned
NCI E-173-1997-0-PCT-02 MURINE INTRACISTERNAL A PARTICLE CONSTITUTIVE TRANSPOR ELEMENTS AND USES THEREOF PCT PCT PCT/US1998/027792 Expired
NHLBI E-124-1998-0-US-01 METHOD FOR MRI VENOGRAPHY AND ARTERIAL AND VENOUS DISCRIMINATION US ORD 09/221,500 6192264 Expired PDF
NCI E-200-1994-2-EP-07 Monomeric and Dimeric Arylisoquinoline Alkaloids and Derivatives Thereof EP National Stage 98966748.0 Abandoned
NCI E-091-1999-0-US-03 Indentification of a Transforming Fragment of Herpes Simplex Type 2 and Detection Thereof in Clinical Specimens US National Stage 09/202,918 6617103 Expired PDF
NCI E-200-1994-2-AU-04 Monomeric and Dimeric Arylisoquinoline Alkaloids and Derivatives Thereof AU National Stage 24496/99 Abandoned
NICHD E-010-1998-1-AU-02 The Protein Tyrosine Kinase Substrate LAT and Its Use in the Identification of (Ant) Agonists of the Kinase AU National Stage 22047/99 Abandoned
NCI E-200-1994-2-PCT-02 MONOMERIC AND DIMERIC ARYLISOQUINOLINE ALKALOIDS AND DERIVATIVES THEREOF PCT PCT PCT/US1998/027407 Expired
NICHD E-010-1998-1-PCT-01 THE PROTEIN TYROSINE KINASE SUBSTRATE LAT AND ITS USE IN THE IDENTIFICATION OF (ANT)AGONISTS OF THE KINASE PCT PCT PCT/US1998/027400 Expired
NIAID E-246-2001-0-PCT-02 Immunization For Ebola Virus Infection PCT PCT PCT/US1998/027364 Expired
NCI E-200-1994-2-BR-05 Monomeric and Dimeric Arylisoquinoline Alkaloids and Derivatives Thereof BR National Stage PI9814575-4 Abandoned
NICHD E-010-1998-1-EP-04 The Protein Tyrosine Kinase Substrate LAT and its Use in the Identification of (Ant) Agonists of the Kinase EP National Stage 98966063.4 Abandoned
NIAID E-246-2001-0-EP-03 Immunization For Ebola Virus Infection EP National Stage 98964877.9 Abandoned